Antiasthmatic APIs are a class of drugs that can reduce and terminate asthma attacks. Commonly used antiasthmatic APIs are divided into adrenomimetics, including epinephrine, ephedrine, isoproterenol, albuterol, etc., M choline receptors blockings, including isopropyl atropine, amidoamine, etc., theophyllines, including aminophylline, etc., drugs that inhibit the release of allergic active substances, such as disodium cromoglycate, etc., and adrenocortical hormones, such as beclozone propionate (BDP), and methylprednisolone.

Protheragen offers a full range of antiasthmatic APIs to support customer research worldwide.